CWM
ABBV icon

Centricity Wealth Management’s AbbVie ABBV Stock Holding History

Centricity Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$178K Hold
958
– – 0.14% 80
2025
Q1 		$201K Hold
958
– – 0.18% 72
2024
Q4 		$170K Buy
+958
New +$176K 0.16% 83

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Centricity Wealth Management's ABBV Position: Q2 2025 in Review

Centricity Wealth Management held its AbbVie (ABBV) position steady in Q2 2025 at 958 shares worth $178K. The position accounts for 0.14% of the portfolio, ranked #80.

Centricity Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 3 quarters since. The position peaked at $201K in Q1 2025. 3,787 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Centricity Wealth Management held 958 shares of AbbVie worth $178K as of Q2 2025.
  • Centricity Wealth Management left its AbbVie share count unchanged in Q2 2025.
  • AbbVie made up 0.14% of Centricity Wealth Management's portfolio in Q2 2025, its #80 holding.
  • Centricity Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 3 quarters since.
  • Centricity Wealth Management's AbbVie position peaked at $201K in Q1 2025.
  • 3,787 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.